slide1 n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Global Hepatitis B Vaccines Market 2014-2018 PowerPoint Presentation
Download Presentation
Global Hepatitis B Vaccines Market 2014-2018

Loading in 2 Seconds...

play fullscreen
1 / 9

Global Hepatitis B Vaccines Market 2014-2018 - PowerPoint PPT Presentation


  • 176 Views
  • Uploaded on

About Hepatitis B Vaccines Hepatitis B is an inflammatory condition that occurs due to infection by hepatitis B virus. Hepatitis B virus is an enveloped virus that belongs to the family of hepadnavirus. It contains a circular genome with partially double-stranded DNA. The virus interferes with the normal functioning of the liver cells. Following the viral infection, the immune system is activated against virus and hepatocytes infected with viruses. This, in turn, leads to the inflammation of the liver. Extra-hepatic manifestations of hepatitis B include polyarteritis nodosa, Gianotti-Crosti syndrome, transient serum sickness-like syndrome, and membranous glomerulonephritis. Perinatal transmission of hepatitis B virus is the most common mode of infection spread. Age of a person at the time of infection and infecting dose of virus are important factors that determine the severity of acute or chronic hepatitis B. Most of the patients suffering from acute hepatitis B recover spontaneously without significant consequences. The chronic form of infection, in some cases, can progress up to cirrhosis and liver cancer. Hepatitis B infection can be prevented by immunization with hepatitis B vaccines. Get full access of the report at: http://www.researchbeam.com/global-hepatitis-b-vaccines-2014-2018-market

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Global Hepatitis B Vaccines Market 2014-2018' - Alexus


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
slide1

Global Hepatitis B Vaccines Market 2014-2018

Publish By: Technovia

Toll Free: +1 (855) 711-1555

Email: sales@researchbeam.com

slide2

Report Overview

About Hepatitis B Vaccines

Hepatitis B is an inflammatory condition that occurs due to infection by hepatitis B virus. Hepatitis B virus is an enveloped virus that belongs to the family of hepadnavirus. It contains a circular genome with partially double-stranded DNA. The virus interferes with the normal functioning of the liver cells. Following the viral infection, the immune system is activated against virus and hepatocytes infected with viruses. This, in turn, leads to the inflammation of the liver. Extra-hepatic manifestations of hepatitis B include polyarteritisnodosa, Gianotti-Crosti syndrome, transient serum sickness-like syndrome, and membranous glomerulonephritis. Perinatal transmission of hepatitis B virus is the most common mode of infection spread. Age of a person at the time of infection and infecting dose of virus are important factors that determine the severity of acute or chronic hepatitis B. Most of the patients suffering from acute hepatitis B recover spontaneously without significant consequences. The chronic form of infection, in some cases, can progress up to cirrhosis and liver cancer. Hepatitis B infection can be prevented by immunization with hepatitis B vaccines.

TechNavio'sanalysts forecast the Global Hepatitis B Vaccines market to grow at a CAGR of 4.00 percent over the period 2013-2018.

slide3

Report Overview

Key Regions

• Americas

• APAC

• EMEA

Key Vendors

• GlaxoSmithKline

• Merck

• Sanofi Pasteur

Other Prominent Vendors

• Dynavax Technologies

• Janssen Pharmaceuticals

• LG Life Sciences

• Kaketsuken

• Shenzhen Kangtai Biological Products

Market Driver

• Increased Awareness about Hepatitis B Infection and Prevention

• For a full, detailed list, view our report

Get full access of the report at: http://www.researchbeam.com/global-hepatitis-b-vaccines-2014-2018-market

slide4

Report Overview

Market Challenge

• Inadequate Vaccine Coverage

• For a full, detailed list, view our report

Market Trend

• Combination Vaccines

• For a full, detailed list, view our report

Key Questions Answered in this Report

• What will the market size be in 2018 and what will the growth rate be?

• What are the key market trends?

• What is driving this market?

• What are the challenges to market growth?

• Who are the key vendors in this market space?

• What are the market opportunities and threats faced by the key vendors?

• What are the strengths and weaknesses of the key vendors?

slide5

Table Of Content

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Disease Overview

05.1 Hepatitis B: Acute and Chronic Infection

slide6

Table Of Content

05.2 Hepatitis B: Geographical Distribution

05.3 Hepatitis B: Estimated National Immunization Coverage

05.3.1 Hepatitis B Birth Dose Vaccine

05.3.2 Third Dose of Hepatitis B Vaccine

05.4 Chronic Disease Prone Individuals for Hepatitis B

05.5 Hepatitis B: Diagnosis

05.5.1 Serological Markers

05.5.2 Hepatitis B Serologic Test Interpretation

06. Introduction

07. Market Landscape

slide7

List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Pathway of Hepatitis B Progression

Exhibit 3: Number of Hepatitis B Birth Doses Administered in WHO Regions

Exhibit 4: Trend of Hepatitis B Birth Doses Administered in WHO Regions 2000-2013

Exhibit 5: Percentage Share of Different Regions in 2013

Exhibit 6: Number of Third Doses of Hepatitis B Administered in WHO Regions

Exhibit 7: Trend of Third Doses of Hepatitis B Administered in WHO Regions 2000-2013

Exhibit 8: Percentage Share of Different Regions in 2013

Exhibit 9: Comparison of Third Dose and Birth Dose in 2013 in WHO Regions

Exhibit 10: Disease Progression of Hepatitis B

slide8

List of Exhibits

Exhibit 11: Significance of Serological Markers

Exhibit 12: Interpretation of Serological Markers

Exhibit 13: Global Hepatitis B Vaccines Market 2013-2018 (US$ million)

Exhibit 14: Global Hepatitis B Vaccines Market Segmentation by Composition

Exhibit 15: Dosage Regimen of Engerix-B

Exhibit 16: Dosage Regimen of Fendrix

Exhibit 17: Dosage Regimen of Recombivax HB

Exhibit 18: Dosage Regimen of Infanrixhexa

To make an enquiry before purchasing the report, visit at: http://www.researchbeam.com/global-hepatitis-b-vaccines-2014-2018-market/purchase-enquiry

slide9

Contact Us

Direct: +1 (617) 674-4143

Toll Free: +1 (855) 711-1555

Fax: +1 (855) 550-5975

Web: www.researchbeam.com

Email: sales@researchbeam.com

Deep

5320 SW Macadam Avenue,

Suite 100, Portland, OR 97239

United States